Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Fairbanks, Carolyn A.
Stone, Laura S.
and
Wilcox, George L.
2009.
Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.
Pharmacology & Therapeutics,
Vol. 123,
Issue. 2,
p.
224.
Gao, Yanlin
Sakurai, Mayumi
Takeda, Hisashi
Higashide, Tomomi
Kawase, Kazuhide
and
Sugiyama, Kazuhisa
2010.
Association between Genetic Polymorphisms of Adrenergic Receptor and Diurnal Intraocular Pressure in Japanese Normal-Tension Glaucoma.
Ophthalmology,
Vol. 117,
Issue. 12,
p.
2359.
Linden, Rafael
Martins, Rodrigo A.P.
Silveira, Mariana S.
Borges, Helena L.
Sholl-Franco, Alfred
Fragel-Madeira, Lucianne
and
Dudenhoeffer-Carneiro, Ana Carolina
2010.
Perspectives of Stem Cells.
p.
191.
Lambert, Wendi S
Ruiz, Lupe
Crish, Samuel D
Wheeler, Larry A
and
Calkins, David J
2011.
Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons.
Molecular Neurodegeneration,
Vol. 6,
Issue. 1,
Crooke, Almudena
Huete-Toral, Fernando
Martínez-Águila, Alejandro
Alarma-Estrany, Pilar
and
Pintor, Jesús
2011.
Regulation of ocular adrenoceptor genes expression by 5-MCA-NAT.
Pharmacogenetics and Genomics,
Vol. 21,
Issue. 9,
p.
587.
Krupin, Theodore
Liebmann, Jeffrey M.
Greenfield, David S.
Ritch, Robert
and
Gardiner, Stuart
2011.
A Randomized Trial of Brimonidine Versus Timolol in Preserving Visual Function: Results From the Low-pressure Glaucoma Treatment Study.
American Journal of Ophthalmology,
Vol. 151,
Issue. 4,
p.
671.
Razy-Krajka, Florian
Brown, Euan R
Horie, Takeo
Callebert, Jacques
Sasakura, Yasunori
Joly, Jean-Stéphane
Kusakabe, Takehiro G
and
Vernier, Philippe
2012.
Monoaminergic modulation of photoreception in ascidian: evidence for a proto-hypothalamo-retinal territory.
BMC Biology,
Vol. 10,
Issue. 1,
Shih, Grace C
and
Calkins, David J
2012.
Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action.
Expert Review of Ophthalmology,
Vol. 7,
Issue. 2,
p.
161.
Dal Monte, Massimo
Casini, Giovanni
la Marca, Giancarlo
Isacchi, Benedetta
Filippi, Luca
and
Bagnoli, Paola
2013.
Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice.
Experimental Eye Research,
Vol. 111,
Issue. ,
p.
27.
Pfeiffer, Norbert
Lamparter, Julia
Gericke, Adrian
Grus, Franz H.
Hoffmann, Esther M.
and
Wahl, Jochen
2013.
Neuroprotection of medical IOP-lowering therapy.
Cell and Tissue Research,
Vol. 353,
Issue. 2,
p.
245.
Chen, Yu
Palczewska, Grazyna
Mustafi, Debarshi
Golczak, Marcin
Dong, Zhiqian
Sawada, Osamu
Maeda, Tadao
Maeda, Akiko
and
Palczewski, Krzysztof
2013.
Systems pharmacology identifies drug targets for Stargardt disease–associated retinal degeneration.
Journal of Clinical Investigation,
Vol. 123,
Issue. 12,
p.
5119.
Grove, Karen
Dobish, Julia
Harth, Eva
Ingram, Martha-Conley
Galloway, Robert L.
and
Mawn, Louise A.
2014.
Trans-meningeal drug delivery to optic nerve ganglion cell axons using a nanoparticle drug delivery system.
Experimental Eye Research,
Vol. 118,
Issue. ,
p.
42.
Reichenbach, Andreas
and
Bringmann, Andreas
2015.
Retinal Glia.
Colloquium Series on Neuroglia in Biology and Medicine: from Physiology to Disease,
Vol. 2,
Issue. 1,
p.
1.
Du, Yunpeng
Cramer, Megan
Lee, Chieh Allen
Tang, Jie
Muthusamy, Arivalagan
Antonetti, David A.
Jin, Hui
Palczewski, Krzysztof
and
Kern, Timothy S.
2015.
Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability.
The FASEB Journal,
Vol. 29,
Issue. 5,
p.
2194.
Park, Yong
Ellis, Dorette
Mueller, Brett
Stankowska, Dorota
and
Yorio, Thomas
2016.
Pharmacologic Therapy of Ocular Disease.
Vol. 242,
Issue. ,
p.
3.
Nizari, Shereen
Guo, Li
Davis, Benjamin M
Normando, Eduardo M
Galvao, Joana
Turner, Lisa A
Bizrah, Mukhtar
Dehabadi, Mohammad
Tian, Kailin
and
Cordeiro, M Francesca
2016.
Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection.
Cell Death & Disease,
Vol. 7,
Issue. 12,
p.
e2514.
Gemenetzi, M
and
Lotery, A J
2016.
Complement pathway biomarkers and age-related macular degeneration.
Eye,
Vol. 30,
Issue. 1,
p.
1.
Faria‐Silva, Raphael
Rezende, Daniel Câmara de
Ribeiro, Juarez Mundim
Gomes, Telmo Heleno
Oliveira, Braulio Antônio Maciel Faria Mota
Pereira, Fábio Maciel R.
Almeida Filho, Ildeu Afonso de
and
Carvalho Junior, Antônio Enéas Rangel de
2016.
Associação de clonidina e ropivacaína no bloqueio de plexo braquial para artroscopia de ombro.
Brazilian Journal of Anesthesiology,
Vol. 66,
Issue. 4,
p.
335.
Faria-Silva, Raphael
de Rezende, Daniel Câmara
Ribeiro, Juarez Mundim
Gomes, Telmo Heleno
Oliveira, Braulio Antônio Maciel Faria Mota
Pereira, Fábio Maciel R.
de Almeida Filho, Ildeu Afonso
and
de Carvalho Junior, Antônio Enéas Rangel
2016.
Association of clonidine and ropivacaine in brachial plexus block for shoulder arthroscopy.
Brazilian Journal of Anesthesiology (English Edition),
Vol. 66,
Issue. 4,
p.
335.
Jutley, Gurjeet
Luk, Sheila MH
Dehabadi, Mohammad H
and
Cordeiro, M Francesca
2017.
Management of Glaucoma As a Neurodegenerative Disease.
Neurodegenerative Disease Management,
Vol. 7,
Issue. 2,
p.
157.